Continuous glucose monitoring following pancreatectomy with islet autotransplantation in children
- 12 June 2017
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 21 (7)
Abstract
Aim was to determine whether CGM could accurately monitor blood glucose concentration in the immediate postoperative period following pancreatectomy with IAT in children. CGM was used in nine patients undergoing IAT at our institution between April 2015 and September 2016 (eight total pancreatectomy and one subtotal pancreatectomy). MAD and MARD of CGM values compared to time‐matched serum blood glucose were calculated during the first 5 days of ICU admission. Goal range was defined as 70‐140 mg/dL and out‐of‐range was >140 mg/dL or P=.74). By Clarke error grid analysis, 100% of paired values were in clinically acceptable zones. By surveillance error grid analysis, 96% of paired values were within clinically acceptable agreement. CGM is a reliable tool in monitoring glycemic control in the immediate postoperative period following pancreatectomy with IAT in children.Keywords
Funding Information
- Cincinnati Children's Hospital Medical Center Academic and Research Committee
This publication has 18 references indexed in Scilit:
- Accuracy of Continuous Glucose Monitoring in Patients After Total Pancreatectomy with Islet AutotransplantationDiabetes Technology & Therapeutics, 2016
- Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot StudyDiabetes Technology & Therapeutics, 2016
- Effects of pH, lactate, hematocrit and potassium level on the accuracy of continuous glucose monitoring (CGM) in pediatric intensive care unitItalian Journal of Pediatrics, 2015
- Pancreatogenic Diabetes after Pancreatic ResectionPancreatology, 2011
- Continuous glucose monitors prove highly accurate in critically ill childrenCritical Care, 2010
- Real-Time Continuous Glucose Monitoring in Critically Ill PatientsDiabetes Care, 2009
- Numerical and Clinical Accuracy of a Continuous Glucose Monitoring System during Intravenous Insulin Therapy in the Surgical and Burn Intensive Care UnitsJournal of Diabetes Science and Technology, 2009
- Intensive Insulin Therapy in the Intensive Care UnitDiabetes Care, 2006
- β-Cell Death and Mass in Syngeneically Transplanted Islets Exposed to Short- and Long-Term HyperglycemiaDiabetes, 2002
- Vulnerability of Islets in the Immediate Posttransplantation Period: Dynamic Changes in Structure and FunctionDiabetes, 1996